Departments of Medicine, University of Washington, Seattle.
Laboratory Medicine, University of Washington, Seattle.
J Infect Dis. 2020 Mar 28;221(8):1271-1279. doi: 10.1093/infdis/jiz199.
The ubiquitous human pathogens, herpes simplex virus (HSV)-1 and HSV-2, are distinct viral species that diverged approximately 6 million years ago. At least 4 small, ancient HSV-1 × HSV-2 interspecies recombination events have affected the HSV-2 genome, with recombinants and nonrecombinants at each locus circulating today. However, it is unknown whether interspecies recombination can affect other loci and whether new recombinants continue to be generated.
Using 255 newly sequenced and 230 existing HSV genome sequences, we comprehensively assessed interspecies recombination in HSV.
Our findings show that the sizes and locations of interspecies recombination events in HSV-2 are significantly more variable than previously appreciated and that they can impact species-specific T-cell recognition of HSV.
We describe 2 large (>5 kb) recombination events, one of which arose in its current host, demonstrating that interspecies recombination continues to occur today. These results raise concerns about the use of live-attenuated HSV-2 vaccines in high HSV-1 prevalence areas.
单纯疱疹病毒 1 型(HSV-1)和单纯疱疹病毒 2 型(HSV-2)是普遍存在的人类病原体,它们是大约在 600 万年前分化的不同病毒种。至少有 4 个小的、古老的 HSV-1×HSV-2 种间重组事件影响了 HSV-2 基因组,每个基因座都有重组体和非重组体循环存在。然而,目前尚不清楚种间重组是否会影响其他基因座,以及是否有新的重组体继续产生。
我们使用 255 个新测序的和 230 个现有的 HSV 基因组序列,全面评估了 HSV 中的种间重组。
我们的研究结果表明,HSV-2 中种间重组事件的大小和位置比以前认为的更为多变,并且它们可能影响 HSV 的特异性 T 细胞识别。
我们描述了 2 个大的(>5kb)重组事件,其中一个发生在其当前宿主中,表明种间重组仍在今天发生。这些结果引起了人们对在 HSV-1 高流行地区使用活减毒 HSV-2 疫苗的担忧。